Narayana Hrudayalaya Ltd. (IN:NH)
:NH
Want to see IN:NH full AI Analyst Report?
Top Page
Narayana Hrudayalaya Ltd.
(NH)
Select Model
Select Model
Rating:64Neutral
Price Target:
₹2,075.00
â–²(18.14% Upside)
Action:Downgraded
Date:05/26/26
The score is driven primarily by strong financial performance (accelerating revenue growth and improved cash generation), supported by a technically positive trend. These positives are meaningfully offset by elevated valuation (high P/E and low yield) and higher balance-sheet risk from the FY2026 debt increase.
Positive Factors
Accelerating Revenue Growth
Sustained double-digit to high-teens revenue acceleration reflects stronger patient volumes and higher case mix in tertiary services; this growth supports scale economics, revenue diversification across inpatient/outpatient/diagnostics, and provides a multi-month runway for margin expansion if utilization holds.
Negative Factors
Sharp Increase in Leverage
A large one-year jump in debt materially increases financial risk: higher interest costs and tighter covenants reduce flexibility to invest or absorb shocks. If operating growth falters, elevated leverage raises refinancing and solvency risks over the coming 2–6 months.
Read all positive and negative factors
Positive Factors
Negative Factors
Accelerating Revenue Growth
Sustained double-digit to high-teens revenue acceleration reflects stronger patient volumes and higher case mix in tertiary services; this growth supports scale economics, revenue diversification across inpatient/outpatient/diagnostics, and provides a multi-month runway for margin expansion if utilization holds.
Read all positive factors
Narayana Hrudayalaya Ltd. (NH) vs. iShares MSCI India ETF (INDA)
Market Cap
₹389.35B
Dividend Yield0.24%
Average Volume (3M)80.08K
Price to Earnings (P/E)48.6
Beta (1Y)0.76
Revenue Growth41.43%
EPS Growth2.10%
CountryIN
Employees11,659
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)41.53
Shares Outstanding204,360,800
10 Day Avg. Volume19,057
30 Day Avg. Volume80,081
Financial Highlights & Ratios
PEG Ratio19.78
Price to Book (P/B)7.32
Price to Sales (P/S)4.21
P/FCF Ratio55.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)56.52
Revenue Forecast (FY)₹104.64B
Narayana Hrudayalaya Ltd. Business Overview & Revenue Model
Company Description
Narayana Hrudayalaya Limited, established in 2000 and headquartered in Bengaluru, India, operates as a prominent provider of medical and healthcare services. The company oversees and manages a diverse range of healthcare facilities, encompassing h...
How the Company Makes Money
NH primarily makes money by delivering hospital-based healthcare services and charging patients (or their insurers/employers/government schemes) for clinical care episodes and related hospital services. Key revenue streams typically include: (1) I...
Narayana Hrudayalaya Ltd. Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
58
Neutral
Cash Flow
71
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 59.93B | 78.96B | 54.83B | 48.90B | 45.30B | 37.01B |
| Gross Profit | 25.76B | 34.78B | 21.12B | 18.41B | 16.76B | 12.13B |
| EBITDA | 13.77B | 16.62B | 12.28B | 11.02B | 9.31B | 6.19B |
| Net Income | 8.45B | 8.06B | 7.90B | 7.89B | 6.06B | 3.42B |
Balance Sheet | ||||||
| Total Assets | 77.42B | 124.74B | 72.65B | 56.25B | 41.62B | 31.30B |
| Cash, Cash Equivalents and Short-Term Investments | 18.24B | 29.27B | 16.27B | 11.04B | 6.51B | 3.01B |
| Total Debt | 23.40B | 58.57B | 24.28B | 16.27B | 8.84B | 7.23B |
| Total Liabilities | 36.80B | 79.35B | 36.37B | 27.39B | 20.30B | 16.40B |
| Stockholders Equity | 40.60B | 45.37B | 36.26B | 28.84B | 21.31B | 14.89B |
Cash Flow | ||||||
| Free Cash Flow | 4.14B | 5.98B | -961.81M | 959.93M | 5.63B | 2.34B |
| Operating Cash Flow | 6.90B | 14.74B | 9.86B | 10.67B | 10.85B | 4.85B |
| Investing Cash Flow | -5.24B | -37.19B | -13.25B | -14.58B | -11.74B | -2.67B |
| Financing Cash Flow | -2.09B | 25.07B | 5.44B | 4.88B | 877.41M | -1.59B |
Narayana Hrudayalaya Ltd. Technical Analysis
Positive
1756.45
Price Trends
1855.32
Positive
1800.12
Positive
1817.51
Positive
Market Momentum
8.25
Positive
55.87
Neutral
57.66
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:NH, the sentiment is Positive. The current price of 1756.45 is below the 20-day moving average (MA) of 1905.71, below the 50-day MA of 1855.32, and below the 200-day MA of 1817.51, indicating a bullish trend. The MACD of 8.25 indicates Positive momentum. The RSI at 55.87 is Neutral, neither overbought nor oversold. The STOCH value of 57.66 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:NH.
Narayana Hrudayalaya Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹1.22T | 62.85 | ― | 0.27% | 15.76% | 34.29% | |
67 Neutral | ₹736.31B | 70.44 | ― | 0.11% | 17.28% | 34.55% | |
66 Neutral | ₹346.44B | 62.91 | ― | 0.04% | 19.44% | 15.55% | |
64 Neutral | ₹389.35B | 48.63 | ― | 0.24% | 41.43% | 2.10% | |
63 Neutral | ₹409.32B | 101.71 | ― | 0.84% | 12.20% | -93.03% | |
61 Neutral | ₹1.06T | 72.69 | ― | 0.14% | 19.14% | 34.04% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:NH
Narayana Hrudayalaya Ltd.
1,924.95
-59.23
-2.99%
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,487.65
1,501.88
21.50%
IN:ASTERDM
Aster DM Healthcare Ltd.
766.05
192.16
33.48%
IN:FORTIS
Fortis Healthcare Ltd.
971.40
206.85
27.06%
IN:MAXHEALTH
Max Healthcare Institute Ltd
1,078.00
-118.12
-9.88%
IN:MEDANTA
Global Health Limited
1,303.95
175.86
15.59%
Narayana Hrudayalaya Ltd. Corporate Events
Narayana Hrudayalaya Publishes FY 2026 Audited Results in Newspapers
May 24, 2026
Narayana Hrudayalaya Limited has published the audited standalone and consolidated financial results for the quarter and full financial year ended March 31, 2026 in leading newspapers. The disclosures in English and Kannada editions demonstrate co...
Narayana Hrudayalaya clears FY26 results, dividend and major debt-raising mandate
May 22, 2026
Narayana Hrudayalaya Ltd. reported that its board has approved the audited standalone and consolidated financial results for the quarter and year ended 31 March 2026, with the statutory auditors issuing an unmodified opinion, underscoring the inte...
Narayana Hrudayalaya Sets Dividend Record Date and Plans Debt Issuance, AGM
May 22, 2026
Narayana Hrudayalaya’s board has approved the audited standalone and consolidated financial results for the quarter and year ended 31 March 2026, with the statutory auditor issuing an unmodified opinion. The company will hold its 26th annual...
Narayana Hrudayalaya Clears FY26 Results, Proposes Dividend and New Debt Issuance Mandate
May 22, 2026
Narayana Hrudayalaya Ltd.’s board has approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, with the statutory auditors issuing an unmodified opinion, underscoring the robustness of...
Narayana Hrudayalaya Files FY26 Investor Presentation With Stock Exchanges
May 22, 2026
Narayana Hrudayalaya Ltd. has submitted an investor presentation to the stock exchanges covering its financial and operational performance for the quarter and full year ended March 31, 2026. The filing, addressed to both BSE and NSE, indicates the...
Narayana Hrudayalaya Delivers 44% FY26 Revenue Growth on Expanding Global Footprint
May 22, 2026
Narayana Hrudayalaya reported a sharp jump in consolidated operating revenue to ₹25,938 million in Q4 FY26, up 75.8% year-on-year, driven by strong growth across India, the Cayman Islands and its recently acquired U.K. operations. Adjusted E...
Narayana Hrudayalaya Clears FY26 Results, Dividend and Rs 1,500-Crore Debt Plan
May 22, 2026
Narayana Hrudayalaya’s board has approved its audited standalone and consolidated financial results for the quarter and full year ended March 31, 2026, with the statutory auditors issuing an unmodified opinion, underscoring the strength and ...
Narayana Hrudayalaya Advances NCLT Scheme of Arrangement With NH Integrated Care
May 2, 2026
Narayana Hrudayalaya Limited has notified stock exchanges that it has published the statutory Form NCLT-3A newspaper advertisement related to a Scheme of Arrangement between NH Integrated Care Private Limited as the demerged company and Narayana H...
Narayana Hrudayalaya shareholders and creditors back scheme of arrangement
Apr 3, 2026
Narayana Hrudayalaya Ltd. has disclosed the voting results and scrutinizer’s report for the National Company Law Tribunal-convened meetings of its equity shareholders, secured creditors and unsecured creditors held on April 2, 2026 via video...
Narayana Hrudayalaya shareholders and creditors back scheme of arrangement with near-unanimous vote
Apr 3, 2026
Narayana Hrudayalaya Ltd. has reported the voting outcomes of court-convened meetings of its equity shareholders, secured creditors and unsecured creditors held on April 2, 2026 via video conferencing, as directed by the National Company Law Tribu...
Narayana Hrudayalaya Schedules Investor Meeting With Key Institutional Funds
Mar 25, 2026
Narayana Hrudayalaya Ltd. has announced that its management will meet with analysts and institutional investors representing Premji, Magma and Arohi in a group, in-person meeting arranged by ICICI Securities on March 27, 2026, at 10:30 a.m. IST. T...
Narayana Hrudayalaya Lines Up Full-Day Investor Meetings on March 23, 2026
Mar 21, 2026
Narayana Hrudayalaya has scheduled a series of investor and analyst meetings on March 23, 2026, in Mumbai, as disclosed under Indian listing regulations. The sessions will run from 10 a.m. to 5 p.m. IST and are intended to engage a broad base of i...
Narayana Hrudayalaya Creates UK Property Arm to Support Hospital Expansion
Mar 13, 2026
Narayana Hrudayalaya’s wholly owned step-down subsidiary, Narayana Hrudayalaya UK Ltd., has incorporated a new private company in the United Kingdom, Practice Plus Group Property Ltd., with a paid-up share capital of GBP 1,000 to function as...
Narayana Hrudayalaya Sets April 2026 Creditor and Shareholder Meetings for Restructuring Scheme
Feb 26, 2026
Narayana Hrudayalaya has scheduled meetings of its shareholders and secured and unsecured creditors, alongside those of NH Integrated Care Private Limited, on 2 April 2026 via video conferencing, as directed by the National Company Law Tribunal in...
Narayana Hrudayalaya Sets April Meetings on NH Integrated Care Demerger Scheme
Feb 26, 2026
Narayana Hrudayalaya Ltd. has scheduled meetings of its shareholders and secured and unsecured creditors, along with those of NH Integrated Care Private Limited, on April 2, 2026, following directions from the National Company Law Tribunal’s...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.